Clinical Use of Ketamine in Suicide Prevention 

Presented by Alan F. Schatzberg, MD, Stanford School of Medicine
Since acute prevention of suicide in people with mood disorders remains a major unsolved issue, ketamine has received much attention as an antidepressant treatment. In this talk, Schatzberg reviews the data on ketamine, and discusses the research he and his colleagues are conducting to effectively treat suicidal patients with the medication.